Moderately hypofractionated radiotherapy, both isodose and dose-escalated, led to progression-free survival outcomes similar to that achieved with conventionally fractionated radiotherapy in patients ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

A CUTTING-EDGE cold laser therapy could effectively treat prostate cancer and slash the risk of any debilitating side effects. Australian researchers discovered that the new treatment could ...

Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...

UHF noninferior to conventionally fractionated radiotherapy for men with intermediate- to high-risk localized disease. (HealthDay News) — Ultra-hypofractionated (UHF) radiotherapy delivered over two ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.

According to data from two phase III trials presented at this year's American Society of Clinical Oncology Genitourinary Cancers Symposium, patients with high-risk prostate cancer had a significantly ...

Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.

A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

The 2 groups--those receiving ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy--had similar overall survival, which was 81% and 79%, respectively, at 10 years.